Medically reviewed by Matthew Wosnitzer, MD Castration-resistant prostate cancer (CRPC) is a type of advanced prostate cancer ...

April 8, 2025 Study of persistence and adherence to ADT in prostate cancer: relugolix, degarelix, and GnRH agonists in the US. April 8, 2025 New Study Published in Clinical Cancer Research Validates ...

The Georgetown University Lombardi Comprehensive Cancer Center held a lecture on how certain white blood cells in the immune system can contribute to bone metastatic prostate cancer as part of their ...

The aim was to compare serum TST recovery between LHRH agonists and LHRH antagonists. A total of 131 patients who underwent radiation therapy with ADT for prostate cancer were retrospectively analyzed ...

It will significantly improve accuracy compared to the approach used in current clinical practice. Prostate cancer is the second most prevalent type of cancer, and the third leading cause of ...

Former “Bachelorette” Katie Thurston confirmed Friday on Instagram that her breast cancer is Stage 4 and has spread to her liver. In a candid update to viewers, set 43 days after she received ...

“I think we now have really robust data showing that earlier treatment intensification with combination regimens does lead to improved survival for patients with metastatic hormone-sensitive prostate ...

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has granted approval for trofolastat (RoTecPSMA), a prostate-specific membrane antigen (PSMA)-targeting agent for detecting ...

This article is brought to you by our exclusive subscriber partnership with our sister title USA Today, and has been written by our American colleagues. It does not necessarily reflect the view of ...

99.8% tumor growth inhibition achieved with a single dose of ATNM-400 in preclinical prostate cancer models – ATNM-400 accumulated in tumors for up to 144 hours and showed minimal uptake in healthy ...

Local anesthetic transperineal (LATP) biopsy is increasingly favored for prostate cancer detection due to lower infectious risks compared to transrectal ultrasound (TRUS) biopsy. A U.K.-based ...